Drug Markets/Paricalcitol

Paricalcitol

8 NDCs across 4 manufacturers|8 Generic,0 Brand

Paricalcitol is used to treat hyperparathyroidism, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Apr 17, 1998, and the first generic was approved Jul 27, 2011. FDA's Orange Book lists 21 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $3 million on Paricalcitol across 28,000 claims for 6,476 beneficiaries.

Paricalcitol is available as 8 NDCs from 4 manufacturers (8 generic, 0 brand), with NADAC prices from $1.24 to $12.97 per EAthe most expensive product costs about 10× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

8

8G / 0B

Manufacturers

4

competing in market

Price Spread

$1.24 – $12.97

per EA

7d Activity

10-2 flat

avg +4.5% WoW · of 8 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

8 NDCs total, 8 shown

Frequently Asked Questions

What is Paricalcitol used to treat?

Paricalcitol is used to treat hyperparathyroidism, per the National Library of Medicine's MED-RT classification.

When did Paricalcitol become available as a generic?

FDA approved the first generic Paricalcitol (ANDA) on Jul 27, 2011. The Orange Book currently lists 21 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Paricalcitol?

In 2024, Medicare Part D spent $3 million on Paricalcitol across 28,000 claims for 6,476 beneficiaries.

How many Paricalcitol products are on the market?

The Paricalcitol drug market contains 8 NDCs from 4 manufacturers — 8 generic and 0 brand products.

What is the price range for Paricalcitol?

NADAC reference prices for Paricalcitol range from $1.2364 to $12.9667 per EA — the most expensive product costs about 10× the cheapest.

Which manufacturers make Paricalcitol?

4 manufacturers list Paricalcitol in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (2), Bionpharma Inc. (2), Aurobindo Pharma Limited (2), Time-Cap Labs Inc. (2).

How has the price of Paricalcitol changed recently?

Over the past 7 days, 10 Paricalcitol NDCs rose and 0 fell, with a market-wide average change of +4.5%.